1. Evaluation of lipid-lowering therapy in patients with definite diagnosis of heterozygous familial hypercholesterolemia in Lodz. (August 2022) Authors: Gorzelak-Pabiś, P.; Pawlos, A.; Staciwa, Z.; Krulikowska, A.; Broncel, M. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SGLT2 inhibitors may reverse the damaging effect of oxidized cholesterol on the integrity of HUVECs and alleviate associated inflammatory response. (August 2022) Authors: Pawlos, A.; Broncel, M.; Woźniak, E.; Gorzelak-Pabiś, P. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗